Thermo Fisher Scientific Inc. (TMO)
Automate Your Wheel Strategy on TMO
With Tiblio's Option Bot, you can configure your own wheel strategy including TMO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMO
- Rev/Share 115.7037
- Book/Share 134.9841
- PB 4.2698
- Debt/Equity 0.6993
- CurrentRatio 1.4975
- ROIC 0.08
- MktCap 218437430954.0
- FreeCF/Share 16.1667
- PFCF 35.745
- PE 33.1599
- Debt/Assets 0.3463
- DivYield 0.0029
- ROE 0.1311
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | TMO | Barclays | Equal Weight | Overweight | -- | $550 | Sept. 11, 2025 |
| Initiation | TMO | William Blair | -- | Outperform | -- | -- | Aug. 19, 2025 |
| Downgrade | TMO | HSBC Securities | Buy | Hold | -- | $510 | July 24, 2025 |
| Upgrade | TMO | Scotiabank | Sector Perform | Sector Outperform | -- | $590 | July 11, 2025 |
| Downgrade | TMO | UBS | Buy | Neutral | -- | $460 | July 9, 2025 |
| Upgrade | TMO | Bernstein | Market Perform | Outperform | -- | $630 | Jan. 10, 2025 |
| Initiation | TMO | Scotiabank | -- | Sector Perform | -- | -- | Dec. 23, 2024 |
| Initiation | TMO | Redburn Atlantic | -- | Buy | -- | -- | Oct. 14, 2024 |
| Initiation | TMO | Stephens | -- | Overweight | -- | $680 | Oct. 1, 2024 |
| Initiation | TMO | Wells Fargo | -- | Overweight | -- | $670 | Aug. 28, 2024 |
News
Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion
Published: February 25, 2025 by: Reuters
Sentiment: Positive
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion.
Read More
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
Published: February 24, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader.
Read More
Final Trades: Exxon Mobil, Thermo Fisher and Cheniere Energy
Published: February 20, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
Thermo Fisher Scientific Elects New Director to Board
Published: February 19, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12. Ms. Lynch is a seasoned health care executive with over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS), a leading hea.
Read More
About Thermo Fisher Scientific Inc. (TMO)
- IPO Date 1980-03-17
- Website https://www.thermofisher.com
- Industry Medical - Diagnostics & Research
- CEO Marc N. Casper
- Employees 125000